Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in Greek population with multiple sclerosis

Abstract Background Cognitive impairment is experienced by about 50% of patients with Multiple Sclerosis (MS) worldwide and affects their employment, disease management and quality of life in general. The Brief International Cognitive assessment for MS (BICAMS) is a brief, practical and potentially...

Full description

Saved in:
Bibliographic Details
Published in:Multiple sclerosis and related disorders 2016-09, Vol.9, p.68-72
Main Authors: Polychroniadou, E, Bakirtzis, C, Langdon, D, Lagoudaki, R, Kesidou, E, Theotokis, P, Tsalikakis, D, Poulatsidou, K, Kyriazis, O, Boziki, M, Papadopoulos, G, Boura, E, Sintila, L, Hatzigeorgiou, S, Ziamos, C, Ioannidis, P, Karacostas, D, Grigoriadis, N
Format: Article
Language:English
Subjects:
Adult
BICAMS
Cognition
Cognition Disorders - complications
Cognition Disorders - diagnosis
Cognition Disorders - epidemiology
Cognitive reserve
Female
Greece
Humans
Male
Middle Aged
Multiple Sclerosis
Multiple Sclerosis - complications
Multiple Sclerosis - diagnosis
Multiple Sclerosis - epidemiology
Multiple Sclerosis - psychology
Neurology
Neuropsychological Tests
Prevalence
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background Cognitive impairment is experienced by about 50% of patients with Multiple Sclerosis (MS) worldwide and affects their employment, disease management and quality of life in general. The Brief International Cognitive assessment for MS (BICAMS) is a brief, practical and potentially universal battery for cognitive impairment in MS patients. It consists of three tests: the Symbol Digit Modalities Test (SDMT), the California Verbal Learning Test-2 (CVLT-2) and the Brief Visuospatial Memory Test-Revised (BVMT-R). Objective The objective of this study was to validate the BICAMS in Greek MS patients and controls. Methods Forty four MS patients and seventy nine healthy control (HC) participants were recruited and tested. They were group matched for age, education, gender and also premorbid cognitive reserve. All of them completed the three tests of the BICAMS battery. Instead of CVLT-2, the Greek validated form (Greek Verbal Learning Test, GVLT), was used. In addition, cognitive reserve was assessed using the Cognitive Reserve Index questionnaire (CRIq) standardized for the Greek population. Results Significant difference was found in the performance of the two groups in all tests (p
ISSN:2211-0348
2211-0356
DOI:10.1016/j.msard.2016.06.011